<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="activity_corpus\PMC7829697\results\search\plant_compound\results.xml">
  <result pre="effect of Ptychotis verticillata (PV) essential oil and its derivatives," exact="carvacrol" post="and thymol, in AML cell lines. We demonstrated that"/>
  <result pre="in AML cell lines. We demonstrated that a combination of" exact="carvacrol" post="and thymol induced tumor cell death with low toxicity"/>
  <result pre="cell lines. We demonstrated that a combination of carvacrol and" exact="thymol" post="induced tumor cell death with low toxicity on normal"/>
  <result pre="apoptosis inhibitors, we showed that cell death induced by the" exact="carvacrol" post="and thymol combination is caspase-dependent in the HL60 cell"/>
  <result pre="we showed that cell death induced by the carvacrol and" exact="thymol" post="combination is caspase-dependent in the HL60 cell line and"/>
  <result pre="of PV contains several compounds, mostly phenolic components (48.0%) with" exact="carvacrol" post="(44.6%) and thymol (3.4%) as the main compounds [5]."/>
  <result pre="several compounds, mostly phenolic components (48.0%) with carvacrol (44.6%) and" exact="thymol" post="(3.4%) as the main compounds [5]. The chemical structure"/>
  <result pre="(3.4%) as the main compounds [5]. The chemical structure of" exact="carvacrol" post="and thymol is shown in Figure 1 using Microsoft"/>
  <result pre="the main compounds [5]. The chemical structure of carvacrol and" exact="thymol" post="is shown in Figure 1 using Microsoft paint software"/>
  <result pre="we have demonstrated that EO of PV and its constituents," exact="carvacrol" post="and thymol, have shown beneficial effects on different biological"/>
  <result pre="lines. We have also evaluated the potential synergistic effect of" exact="carvacrol" post="and thymol combination regarding leukemic cell death. Drug combinations"/>
  <result pre="have also evaluated the potential synergistic effect of carvacrol and" exact="thymol" post="combination regarding leukemic cell death. Drug combinations are a"/>
  <result pre="AML by focusing on the relevance of the combination of" exact="carvacrol" post="and thymol in inducing a potential synergistic cell death"/>
  <result pre="focusing on the relevance of the combination of carvacrol and" exact="thymol" post="in inducing a potential synergistic cell death of cancer"/>
  <result pre="PV EO is mainly composed of phenolic compounds (48.0%) with" exact="carvacrol" post="(44.6%) and thymol (3.4%) as the majors active compounds"/>
  <result pre="mainly composed of phenolic compounds (48.0%) with carvacrol (44.6%) and" exact="thymol" post="(3.4%) as the majors active compounds [5]. In this"/>
  <result pre="part of the work, we studied the combined effect of" exact="carvacrol" post="(car) and thymol (thy) on myeloid leukemic cell death."/>
  <result pre="work, we studied the combined effect of carvacrol (car) and" exact="thymol" post="(thy) on myeloid leukemic cell death. We first tested"/>
  <result pre="myeloid leukemic cell death. We first tested different concentrations of" exact="thymol" post="and carvacrol to determine the concentrations that could be"/>
  <result pre="cell death. We first tested different concentrations of thymol and" exact="carvacrol" post="to determine the concentrations that could be used to"/>
  <result pre="in Figure 3, KG1 cell lines are very sensitive to" exact="carvacrol" post="at 300 ÂµM compared to the HL60 line (Figure"/>
  <result pre="sensitive compared to the other two lines. At 100 ÂµM," exact="thymol" post="can induce complete cell death of KG1 and HL60"/>
  <result pre="Based on these results, we tested two different concentrations of" exact="thymol" post="(25 ÂµM and 50 ÂµM) and carvacrol (200 ÂµM"/>
  <result pre="different concentrations of thymol (25 ÂµM and 50 ÂµM) and" exact="carvacrol" post="(200 ÂµM and 300 ÂµM) to study their potential"/>
  <result pre="KG1 cell line, we observed the potential synergistic effect of" exact="thymol" post="and carvacrol at the different combinations of drug concentrations"/>
  <result pre="line, we observed the potential synergistic effect of thymol and" exact="carvacrol" post="at the different combinations of drug concentrations after both"/>
  <result pre="(Figure 5) that was less sensitive to individual concentrations of" exact="carvacrol" post="and thymol (more than 90% viability after 48 h"/>
  <result pre="that was less sensitive to individual concentrations of carvacrol and" exact="thymol" post="(more than 90% viability after 48 h of treatment"/>
  <result pre="90% viability after 48 h of treatment with 300 ÂµM" exact="carvacrol" post="or 50 ÂµM thymol), the combination of the two"/>
  <result pre="on PBMCs from healthy donors. As shown in Figure 6," exact="carvacrol" post="and thymol show toxicity at very high concentrations (carvacrol"/>
  <result pre="from healthy donors. As shown in Figure 6, carvacrol and" exact="thymol" post="show toxicity at very high concentrations (carvacrol 400 ÂµM"/>
  <result pre="show toxicity at very high concentrations (carvacrol 400 ÂµM and" exact="thymol" post="100 ÂµM), but more than 50% of PBMCs remain"/>
  <result pre="of PV EO could be due to the presence of" exact="thymol" post="and carvacrol and that the combination of the two"/>
  <result pre="EO could be due to the presence of thymol and" exact="carvacrol" post="and that the combination of the two drugs can"/>
  <result pre="(8%) and KG1 (10%) cells even after 48 h of" exact="carvacrol" post="and thymol treatment (Figure 7A). Based on these results,"/>
  <result pre="KG1 (10%) cells even after 48 h of carvacrol and" exact="thymol" post="treatment (Figure 7A). Based on these results, we analyzed"/>
  <result pre="and cellular stress pathways in cell death induced by the" exact="carvacrol" post="and thymol combination. 2.3.3. Protein Confirmation of Apoptotic and"/>
  <result pre="stress pathways in cell death induced by the carvacrol and" exact="thymol" post="combination. 2.3.3. Protein Confirmation of Apoptotic and Reticular Stress"/>
  <result pre="analyzed by Western blot. As shown in Figure 8, the" exact="carvacrol" post="and thymol combination shows a potential synergistic effect by"/>
  <result pre="Western blot. As shown in Figure 8, the carvacrol and" exact="thymol" post="combination shows a potential synergistic effect by inducing the"/>
  <result pre="protein expression of PI3K and p-AKT to determine how the" exact="carvacrol" post="and thymol combination may modulate the antiapoptotic mechanisms of"/>
  <result pre="of PI3K and p-AKT to determine how the carvacrol and" exact="thymol" post="combination may modulate the antiapoptotic mechanisms of cell death"/>
  <result pre="As shown in Figure 8, the potential synergistic effect of" exact="carvacrol" post="and thymol in the induction of leukemic cell death"/>
  <result pre="in Figure 8, the potential synergistic effect of carvacrol and" exact="thymol" post="in the induction of leukemic cell death is also"/>
  <result pre="in combination-treated cells compared to vehicle and cells treated with" exact="carvacrol" post="or thymol separately. These Western blot results confirm that"/>
  <result pre="cells compared to vehicle and cells treated with carvacrol or" exact="thymol" post="separately. These Western blot results confirm that the combination"/>
  <result pre="separately. These Western blot results confirm that the combination of" exact="carvacrol" post="and thymol induces cell death through apoptotic, oxidative, and"/>
  <result pre="Western blot results confirm that the combination of carvacrol and" exact="thymol" post="induces cell death through apoptotic, oxidative, and cell stress"/>
  <result pre="involved in the cell death induced by the combination of" exact="carvacrol" post="and thymol, we first studied the dependence of this"/>
  <result pre="in the three cell lines treated with the combination of" exact="carvacrol" post="and thymol. As shown in Figure 10, carâ€&quot;thy-induced cell"/>
  <result pre="and associated with non-apoptotic pathways. In conclusion, the combination of" exact="thymol" post="and carvacrol has a potential synergistic effect on myeloid"/>
  <result pre="with non-apoptotic pathways. In conclusion, the combination of thymol and" exact="carvacrol" post="has a potential synergistic effect on myeloid leukemia cell"/>
  <result pre="spectrometry. The oil was dominated by phenolic compounds (48.0%) with" exact="carvacrol" post="(44.6%) and thymol (3.4%) as the main compounds. Plant"/>
  <result pre="was dominated by phenolic compounds (48.0%) with carvacrol (44.6%) and" exact="thymol" post="(3.4%) as the main compounds. Plant phenolics constitute one"/>
  <result pre="alternative. Although some reports have shown the anticancer effect of" exact="thymol" post="and carvacrol, no study has yet evaluated the combination"/>
  <result pre="EO and the potential synergistic combination of its two components," exact="carvacrol" post="and thymol, against myeloid leukemic cell lines. This is"/>
  <result pre="toxicity. Recently, we showed that Ptychotis verticillate EO, carvacrol, and" exact="thymol" post="have several positive effects on MSCs, which are known"/>
  <result pre="therapeutic effects of MSCs [6]. Several studies have shown that" exact="carvacrol" post="or thymol may individually induce, in vitro and in"/>
  <result pre="of MSCs [6]. Several studies have shown that carvacrol or" exact="thymol" post="may individually induce, in vitro and in vivo (animal"/>
  <result pre="[11,12]. For leukemic cells, previous studies have shown that both" exact="carvacrol" post="and thymol individually showed cytotoxic effects on the HL60"/>
  <result pre="leukemic cells, previous studies have shown that both carvacrol and" exact="thymol" post="individually showed cytotoxic effects on the HL60 cell line"/>
  <result pre="aimed to investigate the anticancer activity of the combination of" exact="carvacrol" post="and thymol in three different leukemic cell lines that"/>
  <result pre="investigate the anticancer activity of the combination of carvacrol and" exact="thymol" post="in three different leukemic cell lines that are able"/>
  <result pre="AML [21]. Our results showed a potential synergistic effect of" exact="thymol" post="and carvacrol at the different combinations used in the"/>
  <result pre="Our results showed a potential synergistic effect of thymol and" exact="carvacrol" post="at the different combinations used in the KG1 and"/>
  <result pre="line, which was far less sensitive to individual treatment with" exact="carvacrol" post="or thymol, the combination of the two drugs was"/>
  <result pre="effect of PV EO is due to the presence of" exact="thymol" post="and carvacrol and that the combination of the two"/>
  <result pre="PV EO is due to the presence of thymol and" exact="carvacrol" post="and that the combination of the two drugs can"/>
  <result pre="the nontoxic effect of EO compared to the combination of" exact="carvacrol" post="and thymol (carâ€&quot;thy) in normal cells may be due"/>
  <result pre="effect of EO compared to the combination of carvacrol and" exact="thymol" post="(carâ€&quot;thy) in normal cells may be due to the"/>
  <result pre="wide range of annexin+/PI-cells (especially for HL60 cell lines) after" exact="carvacrol" post="and thymol treatment associated with the expression of the"/>
  <result pre="of annexin+/PI-cells (especially for HL60 cell lines) after carvacrol and" exact="thymol" post="treatment associated with the expression of the proapoptotic genes"/>
  <result pre="procaspase-3 and procaspase-9 in cells treated with the combination of" exact="carvacrol" post="and thymol. The GADD45A gene is an indicator of"/>
  <result pre="combination-treated cells compared to untreated cells and cells treated with" exact="carvacrol" post="or thymol alone. Furthermore, the overexpression of the proapoptotic"/>
  <result pre="compared to untreated cells and cells treated with carvacrol or" exact="thymol" post="alone. Furthermore, the overexpression of the proapoptotic gene BCL211"/>
  <result pre="cell death. Together, these results show that the association of" exact="carvacrol" post="and thymol induces cell death through apoptotic, oxidative, and"/>
  <result pre="Together, these results show that the association of carvacrol and" exact="thymol" post="induces cell death through apoptotic, oxidative, and reticular stress"/>
  <result pre="to carâ€&quot;thy. Collectively, these results show that the combination of" exact="carvacrol" post="and thymol induce a potential synergistic cell-death effect against"/>
  <result pre="Collectively, these results show that the combination of carvacrol and" exact="thymol" post="induce a potential synergistic cell-death effect against acute leukemia"/>
  <result pre="in developing a safe and efficient anti-AML strategy based on" exact="thymol" post="and carvacrol combination. Both of these molecules should be"/>
  <result pre="a safe and efficient anti-AML strategy based on thymol and" exact="carvacrol" post="combination. Both of these molecules should be therapeutically evaluated"/>
  <result pre="are few clinical data regarding these molecules. In this context," exact="carvacrol" post="has been approved as a food additive by the"/>
  <result pre="flavorings by the Council of Europe. It is known that" exact="carvacrol" post="has several pharmacological properties including antioxidant, anti-inflammatory, immunomodulatory, antitumor,"/>
  <result pre="clinical study that was conducted to assess the effect of" exact="carvacrol" post="on respiratory symptoms in the veterans exposed to sulfur"/>
  <result pre="sulfur mustard (SM) showed that two months of treatment with" exact="carvacrol" post="reduced inflammatory cytokine and chemokine but increased anti-inflammatory cytokines."/>
  <result pre="was conducted in 2018 to examine the preventive effect of" exact="carvacrol" post="in asthmatic patients during a 2-month treatment period. Pulmonary"/>
  <result pre="In contrast, the vast majority of the published studies regarding" exact="thymol" post="are in vitro or preclinical data. In all of"/>
  <result pre="in vitro or preclinical data. In all of these studies," exact="thymol" post="pre- and co-treatment in rats appear devoid of any"/>
  <result pre="recommend performing clinical trials to determine the exact dosage of" exact="thymol" post="against cancer disease in humans. Interestingly, the effect of"/>
  <result pre="ultimately clinical trials are implemented to evaluate the combination of" exact="carvacrol" post="and thymol for the management of AML. The amelioration"/>
  <result pre="trials are implemented to evaluate the combination of carvacrol and" exact="thymol" post="for the management of AML. The amelioration of compound"/>
  <result pre="regarding the potential synergistic anti-tumoral mechanisms of action of the" exact="thymol" post="and carvacrol combination will provide new onco-therapeutic perspectives for"/>
  <result pre="potential synergistic anti-tumoral mechanisms of action of the thymol and" exact="carvacrol" post="combination will provide new onco-therapeutic perspectives for the management"/>
  <result pre="the highest quality and were used as supplied. Carvacrol (99.9%)," exact="thymol" post="(98.5%), dichlorofluorescin diacetate (DCFH-DA), N-acetyl- l-cysteine (NAC), and trypan"/>
  <result pre="dye exclusion and was always &amp;gt;95%. Essential oil, thymol, and" exact="carvacrol" post="were dissolved in ethanol or DMSO to obtain a"/>
  <result pre="cells/mL) and treated at 50% confluency with EO, thymol, and" exact="carvacrol" post="at the desired concentration for 24 or 48 h."/>
  <result pre="AML cells and PBMCs were treated with different concentrations of" exact="carvacrol" post="(100, 200, 300, and 400 ÂµM) and thymol (25,"/>
  <result pre="concentrations of carvacrol (100, 200, 300, and 400 ÂµM) and" exact="thymol" post="(25, 50, 75, and 100 ÂµM). 4.4. Trypan Blue"/>
  <result pre="was used to evaluate the efficacy of separate or combined" exact="thymol" post="and carvacrol treatments in comparison to control treatment. Cells"/>
  <result pre="to evaluate the efficacy of separate or combined thymol and" exact="carvacrol" post="treatments in comparison to control treatment. Cells were seeded"/>
  <result pre="At 50% confluency, cells were treated in triplicate with different" exact="thymol" post="and carvacrol concentrations as well as their combinations. Then,"/>
  <result pre="confluency, cells were treated in triplicate with different thymol and" exact="carvacrol" post="concentrations as well as their combinations. Then, cells were"/>
  <result pre="Chem. Toxicol.20114953353610.1016/j.fct.2010.11.01921093522 6.BouhtitF.NajarM.AghaD.M.MelkiR.NajimiM.SadkiK.LewalleP.HamalA.LagneauxL.MerimiM.The biological response of mesenchymal stromal cells to" exact="thymol" post="and carvacrol in comparison to their essential oil: An"/>
  <result pre="6.BouhtitF.NajarM.AghaD.M.MelkiR.NajimiM.SadkiK.LewalleP.HamalA.LagneauxL.MerimiM.The biological response of mesenchymal stromal cells to thymol and" exact="carvacrol" post="in comparison to their essential oil: An innovative new"/>
  <result pre="of bone marrow stromal cells into osteoblastsBone2011491219123110.1016/j.bone.2011.08.01321893226 37.KhazdairM.R.BoskabadyM.H.The effect of" exact="carvacrol" post="on inflammatory mediators and respiratory symptoms in veterans exposed"/>
  <result pre="mustard, a randomized, placebo-controlled trialRespir. Med.2019150212910.1016/j.rmed.2019.01.02030961947 38.AlavinezhadA.KhazdairM.R.BoskabadyM.H.Possible therapeutic effect of" exact="carvacrol" post="on asthmatic patients: A randomized, double blind, placebo-controlled, Phase"/>
  <result pre="jejunal mucosa of weaning pigletsAnimal20171119320110.1017/S175173111600139727416730 Figure 1 Chemical structure of" exact="carvacrol" post="and thymol. Figure 2 (A,B) Cell cytotoxicity of Ptychotis"/>
  <result pre="24 h and 48 h treatment with different concentrations of" exact="carvacrol" post="and thymol (individually or in combination). Data represent the"/>
  <result pre="and 48 h treatment with different concentrations of carvacrol and" exact="thymol" post="(individually or in combination). Data represent the mean Â±"/>
  <result pre="24 h and 48 h treatment with different concentrations of" exact="carvacrol" post="and thymol (individually or in combination). Data represent the"/>
  <result pre="and 48 h treatment with different concentrations of carvacrol and" exact="thymol" post="(individually or in combination). Data represent the mean Â±"/>
  <result pre="24 h and 48 h treatment with different concentrations of" exact="carvacrol" post="and thymol (individually or in combination). Data represent the"/>
  <result pre="and 48 h treatment with different concentrations of carvacrol and" exact="thymol" post="(individually or in combination). Data represent the mean Â±"/>
  <result pre="staining after two 48 h treatments with different concentrations of" exact="carvacrol" post="and thymol (individually or in combination). Data were analyzed"/>
  <result pre="two 48 h treatments with different concentrations of carvacrol and" exact="thymol" post="(individually or in combination). Data were analyzed by Kaluza"/>
  <result pre="and p &amp;lt; 0.001 (***). Figure 7 (Aâ€&quot;D) Effect of" exact="carvacrol" post="and thymol combination in cell death induction through apoptotic"/>
  <result pre="&amp;lt; 0.001 (***). Figure 7 (Aâ€&quot;D) Effect of carvacrol and" exact="thymol" post="combination in cell death induction through apoptotic and cell"/>
  <result pre="&amp;lt; 0.001 (***). ns: no significant. Figure 8 Effect of" exact="carvacrol" post="and thymol combination in cell death induction through apoptotic"/>
  <result pre="(***). ns: no significant. Figure 8 Effect of carvacrol and" exact="thymol" post="combination in cell death induction through apoptotic and cell"/>
  <result pre="caspase-3, caspase-9, CHOP, PI3k, pAKT, and B actin expression following" exact="carvacrol" post="and thymol treatment (individually or in combination). A representative"/>
  <result pre="CHOP, PI3k, pAKT, and B actin expression following carvacrol and" exact="thymol" post="treatment (individually or in combination). A representative figure of"/>
  <result pre="three independent experiments is presented. Figure 9 (A,B) Effect of" exact="carvacrol" post="and thymol combination in cell death induction through non-apoptotic"/>
  <result pre="experiments is presented. Figure 9 (A,B) Effect of carvacrol and" exact="thymol" post="combination in cell death induction through non-apoptotic pathways. Flow"/>
  <result pre="0.001 (***). ns: no significant. Figure 10 (A,B) Effect of" exact="carvacrol" post="and thymol combination in cell death induction through non-apoptotic"/>
  <result pre="ns: no significant. Figure 10 (A,B) Effect of carvacrol and" exact="thymol" post="combination in cell death induction through non-apoptotic pathways. Relative"/>
 </snippets>
</snippetsTree>
